Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study
<i>Background and Objectives</i>: Naldemedine is a peripherally acting μ-opioid receptor antagonist that improves opioid-induced constipation. Although clinical trials have excluded patients with poor performance status (PS) and those started on naldemedine early after opioid initiation,...
Guardado en:
Autores principales: | Eriko Hiruta, Yukiyoshi Fujita, Hisao Imai, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Masako Ito, Satoshi Takei, Masato Matsuura, Hiromi Nishiba, Junnosuke Mogi, Mie Kotake, Shiro Koizuka, Koichi Minato |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9baf8d2664d2432e9483df6b1bc9fe63 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on the management of constipation in the elderly: new treatment options
por: Satish SC Rao, et al.
Publicado: (2010) -
Psyllium Powder Laxatives Are Effective Treatment of Constipation in Pregnancy, But What is About Safety?
por: Renata Bor, et al.
Publicado: (2014) -
Evaluation and Management of Intractable Constipation in Children
por: Lusine Ambartsumyan, et al.
Publicado: (2018) -
In the Pregnancy, Psyllium Powder Consumption Could Significantly Prevent Constipation
por: Murat Kekilli, et al.
Publicado: (2014) -
Evaluation of the Growth Parameters in Children with Chronic Functional Constipation
por: Seyed Mohsen Dehghani, et al.
Publicado: (2013)